financetom
Business
financetom
/
Business
/
Eos Energy Enterprises Prices 2031 Convertible Notes, Concurrent Equity Offerings; Agrees to Repurchase $200 Million of 2030 Notes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eos Energy Enterprises Prices 2031 Convertible Notes, Concurrent Equity Offerings; Agrees to Repurchase $200 Million of 2030 Notes
Nov 20, 2025 5:12 AM

07:09 AM EST, 11/20/2025 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) said Thursday that it has priced an upsized $525 million offering of convertible senior notes due 2031 with an interest rate of 1.75% per year, payable semi-annually in arrears, starting June 1.

The company said it has granted the initial purchasers an option to buy up to an additional $75 million in principal amount of notes. The issuance and sale are expected to settle on Monday.

Eos said it has also priced a registered direct offering of 35.9 million shares at $12.78 per share for a limited number of purchasers.

Eos said it estimates net proceeds from the notes offering will be $507.9 million, or $580.5 million if the additional notes are fully purchased.

The company said it plans to use the proceeds from the notes and equity offerings to repurchase a portion of its outstanding 6.75% convertible senior notes due 2030, as well as for general corporate purposes.

Eos said that through a privately negotiated transactions it will repurchase $200 million in principal amount of the 2030 convertible senior notes for $564.6 million, including accrued and unpaid interest. Eos said it may repurchase additional 2030 notes after the offering is completed.

Eos Energy Enterprises ( EOSE ) shares were up more than 14% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Superior Plus First-Quarter Profit Falls 22% as Revenue Weakened, Adjusted EBITDA Rises 15%
Superior Plus First-Quarter Profit Falls 22% as Revenue Weakened, Adjusted EBITDA Rises 15%
May 14, 2024
04:41 PM EDT, 05/14/2024 (MT Newswires) -- Superior Plus ( SUUIF ) , a distributor of propane and other fuels, on Tuesday said its first-quarter profit fell 22% on lower revenue. In its first quarter reporting in US dollars, the company said it earned US$85.2 million, or US$0.30, per share, in the period, down from US$109.3 million, or US$0.47 in...
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
May 14, 2024
04:38 PM EDT, 05/14/2024 (MT Newswires) -- Infinera ( INFN ) reported a Q1 preliminary non-GAAP loss late Tuesday of $0.17 per diluted share, compared with earnings of $0.02 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.13. Preliminary revenue for the quarter ended March 30 was $306.9 million, down from $392.1 million a...
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
May 14, 2024
04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924013129/xslF345X03/form4-05142024_040509.xml ...
Lifestance Health Group Insider Sold Shares Worth $362,567, According to a Recent SEC Filing
Lifestance Health Group Insider Sold Shares Worth $362,567, According to a Recent SEC Filing
May 14, 2024
04:40 PM EDT, 05/14/2024 (MT Newswires) -- Paula Cipollone, Chief Business Transformation Officer, on May 10, 2024, sold 50,278 shares in Lifestance Health Group ( LFST ) for $362,567. Following the Form 4 filing with the SEC, Cipollone has control over a total of 239,915 shares of the company, with 239,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1845257/000095017024059636/xslF345X03/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved